Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CT117: Interim analysis of the Phase 2 clinical trial of the IDO pathway inhibitor indoximod in combination with pembrolizumab for patients with advanced melanoma

Cancer Res (2017) 77 (13_Supplement): CT117.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Jake Lazaroff
  • Diana Bolotin
Dermatologic Clinics (2023) 41 (1): 65.
  • Arian Charehjoo
  • Jamal Majidpoor
  • Keywan Mortezaee
International Immunopharmacology (2023) 118: 110032.
  • Danilo Rocco
  • Vanesa Gregorc
  • Luigi Della Gravara
  • Chiara Lazzari
  • Giovanni Palazzolo
  • Cesare Gridelli
Expert Opinion on Investigational Drugs (2020) 29 (9): 1005.
  • Rui Liu
  • Yang An
  • Wenfeng Jia
  • Yushan Wang
  • Yue Wu
  • Yonghuan Zhen
  • Jun Cao
  • Huile Gao
Journal of Controlled Release (2020) 321: 589.
  • Alexander J. Muller
  • Mark G. Manfredi
  • Yousef Zakharia
  • George C. Prendergast
Seminars in Immunopathology (2019) 41 (1): 41.
  • Tuba N Gide
  • Benjamin M Allanson
  • Alexander M Menzies
  • Peter M Ferguson
  • Jason Madore
  • Robyn P M Saw
  • John F Thompson
  • Georgina V Long
  • James S Wilmott
  • Richard A Scolyer
Histopathology (2019) 74 (6): 817.
  • Biagio Ricciuti
  • Giulia Costanza Leonardi
  • Paolo Puccetti
  • Francesca Fallarino
  • Vanessa Bianconi
  • Amirhossein Sahebkar
  • Sara Baglivo
  • Rita Chiari
  • Matteo Pirro
Pharmacology & Therapeutics (2019) 196: 105.
  • Eric Fox
  • Thomas Oliver
  • Melissa Rowe
  • Sunil Thomas
  • Yousef Zakharia
  • Paul B. Gilman
  • Alexander J. Muller
  • George C. Prendergast
Frontiers in Oncology (2018) 8
  • Ari J. Rosenberg
  • Derek A. Wainwright
  • Alfred Rademaker
  • Carlos Galvez
  • Matthew Genet
  • Lijie Zhai
  • Kristen L. Lauing
  • Mary F. Mulcahy
  • John P. Hayes
  • David D. Odell
  • Craig Horbinski
  • Srinadh Komanduri
  • Marie-Pier Tetreault
  • Kwang-Youn A. Kim
  • Victoria M. Villaflor
Oncotarget (2018) 9 (34): 23482.
  • Lucia Festino
  • Vito Vanella
  • Claudia Trojaniello
  • Paolo A. Ascierto
Expert Review of Clinical Pharmacology (2018) 11 (10): 971.
  • Benjamin L. Solomon
  • Ignacio Garrido-Laguna
Cancer Immunology, Immunotherapy (2018) 67 (11): 1659.
  • Martin W. LaFleur
  • Yuki Muroyama
  • Charles G. Drake
  • Arlene H. Sharpe
The Journal of Immunology (2018) 200 (2): 375.
  • Thomas T DeLeon
  • Yumei Zhou
  • Bolni M Nagalo
  • Raquel T Yokoda
  • Daniel H Ahn
  • Ramesh K Ramanathan
  • Marcela A Salomao
  • Bashar A Aqel
  • Amit Mahipal
  • Tanios S Bekaii-Saab
  • Mitesh J Borad
Immunotherapy (2018) 10 (12): 1077.
  • Daniel L. Suzman
  • Lorraine Pelosof
  • Amy Rosenberg
  • Mark I. Avigan
Liver International (2018) 38 (6): 976.
  • Felicia Rubel
  • Johannes S. Kern
  • Kristin Technau-Hafsi
  • Sibylle Uhrich
  • Kaethe Thoma
  • Georg Häcker
  • Nikolas von Bubnoff
  • Frank Meiss
  • Dagmar von Bubnoff
Journal of Investigative Dermatology (2018) 138 (3): 679.
  • Lucas M.D. Espíndola
  • Renata M. Salhab
  • Carlos Dos Anjos
  • Bernardo Garicochea
  • Rodrigo R. Munhoz
Clinical Skin Cancer (2017) 2 (1-2): 10.
  • George C. Prendergast
  • William P. Malachowski
  • James B. DuHadaway
  • Alexander J. Muller
Cancer Research (2017) 77 (24): 6795.
  • Bingshan Liu
  • Yongping Song
  • Delong Liu
Journal of Hematology & Oncology (2017) 10 (1)
  • Daniel E. Carvajal-Hausdorf
  • Nikita Mani
  • Vamsidhar Velcheti
  • Kurt A. Schalper
  • David L. Rimm
Journal for ImmunoTherapy of Cancer (2017) 5 (1)
  • Carmen S. Yong
  • Daouda Abba Moussa
  • Gaspard Cretenet
  • Sandrina Kinet
  • Valérie Dardalhon
  • Naomi Taylor
FEBS Letters (2017) 591 (19): 3104.
Close Modal

or Create an Account

Close Modal
Close Modal